Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, Richard A, Marayati, Raoud, Flate, Elizabeth L, Volmar, Keith E, Loeza, S Gabriela Herrera, Hoadley, Katherine A, Rashid, Naim U, Williams, Lindsay A +10 more·2015·Nature Genetics

DOI 10.1038/ng.3398

Cited by (1,002)

Items 401–500 of 1,002

Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers
In‐Hye Ham, Dagyeong Lee, Hoon Hur · 2021 · Cancers
Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress
Hideo Tomihara, Federica Carbone, Luigi Perelli, Justin Kwang-Lay Huang, Melinda Soeung, Johnathon Lynn Rose, Frederick Scott Robinson, Yonathan Lissanu, Ningping Feng, Mitsunobu Takeda et al. · 2020 · Cancer Research
Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells
Ian M. Loveless, Samantha B. Kemp, Kailee M. Hartway, Jacob T. Mitchell, Yuesong Wu, Samuel D. Zwernik, Daniel James Salas-Escabillas, Sydney M. Brender, Madison George, Yetunde Makinwa et al. · 2024 · Clinical Cancer Research
Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited – Exploring the “Space”
Konstantin Bräutigam, Kristijan Skok, K Szymoński, Charlotte Vestrup Rift, Eva Karamitopoulou · 2025 · Cancer Letters
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Posaric Bauden, Melinda Rezeli, Yi Jiang et al. · 2018 · Oncotarget
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
Veronique L. Veenstra, Helene Damhofer, Cynthia Waasdorp, L. Bengt van Rijssen, Marc J. van de Vijver, Frederike Dijk, Hanneke W. Wilmink, Marc G. Besselink, Olivier R. Busch, David Kuang-Fu Chang et al. · 2018 · Oncogenesis
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Birnbaum, David J., Finetti, Pascal, Lopresti, Alexia, Gilabert, Marine, Poizat, Flora, Raoul, Jean-Luc, Delpero, Jean-Robert, Moutardier, Vincent, Birnbaum, Daniel, Mamessier, Emilie et al. · 2017 · BMC Medicine
De novo compartment deconvolution and weight estimation of tumor samples using DECODER
Xianlu L. Peng, Richard A. Moffitt, Robert J. Torphy, Keith E. Volmar, Jen Jen Yeh · 2019 · Nature Communications
Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts
Kaiyi Zhu, Lingyi Cai, Chenqian Cui, Juan R. de los Toyos, Dimitris Anastassiou · 2021 · PLoS Computational Biology
Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer
Dirk Bausch, Stefan Fritz, Louisa Bolm, Ulrich Friedrich Wellner, Carlos Fernández‐del‐Castillo, Andrew Louis Warshaw, Sarah P. Thayer, Andrew Scott Liss · 2020 · Angiogenesis
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma
Xiaoying Fan, Ping Lü, Hongwei Wang, Shuhui Bian, Xinglong Wu, Yu Zhang, Yang Liu, Danqi Fu, Lu Wen, Jihui Hao et al. · 2022 · Cell Discovery
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Paloma Valenzuela, S. Perwez Hussain · 2022 · Trends in cancer
Pancreatic cancer microenvironment, to target or not to target?
Ryan Michael Carr, Martín E. Fernández-Zapico · 2016 · EMBO Molecular Medicine
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
Mei Gao, Miranda Lin, Richard A. Moffitt, Marcela d'Alincourt Salazar, Jinha Mark Park, Jeffrey L. Vacirca, Chuan Huang, Kenneth Reed Shroyer, Minsig Choi, Georgios V. Georgakis et al. · 2018 · British Journal of Cancer
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
Rahat Jahan, Koelina Ganguly, Lynette M. Smith, Pranita Atri, Joseph Carmicheal, Yuri M. Sheinin, Satyanarayana Rachagani, Gopalakrishnan Natarajan, Randall E. Brand, Muzafar Ahmad Macha et al. · 2019 · EBioMedicine
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
Chiara Bazzichetto, Claudio Luchini, Fabiana Conciatori, Vanja Vaccaro, Ilaria Di Cello, Paola Mattiolo, Italia Falcone, Gianluigi Ferretti, Aldo Scarpa, Francesco Cognetti et al. · 2020 · International Journal of Molecular Sciences
Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance
Minglei Yang, Cheng-Hao Lin, Yanni Wang, Kang Chen, Haiyue Zhang, Weizhong Li · 2022 · Genome Medicine
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
Donatella Delle Cave, Silvia Buonaiuto, Bruno Sáinz, Marco Fantuz, Maria Mangini, Alessandro Carrer, Annalisa Di Domenico, Tea Teresa Iavazzo, Gennaro Andolfi, Carme Cortina et al. · 2022 · Journal of Experimental & Clinical Cancer Research
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes
Do Young Hyeon, Dowoon Nam, Youngmin Han, Duk Ki Kim, Gibeom Kim, Daeun Kim, Jingi Bae, Seunghoon Back, Dong‐Gi Mun, Inamul Hasan Madar et al. · 2022 · Nature Cancer
Validation and comparison of the molecular classifications of pancreatic carcinomas
David Jérémie Birnbaum, Pascal Finetti, Daniel Birnbaum, Émilie Mamessier, François Bertucci · 2017 · Molecular Cancer
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics
James Thomas Topham, Joanna M. Karasinska, Michael K.C. Lee, Veronika Csizmók, Laura Williamson, Gun Ho Jang, Robert Edward Denroche, Erica S. Tsang, Steve E. Kalloger, Hui‐Li Wong et al. · 2020 · Clinical Cancer Research
Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises
Lin Mei, Wei Du, Wen Wee Ma · 2016 · Journal of Gastrointestinal Oncology
Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors
Xueqiong Zhang, Limei Shen, Qi Liu, Lin Hou, Leaf Huang · 2019 · Journal of Controlled Release
The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer
Robert B. Hamanaka, Gökhan M. Mutlu · 2021 · Amino Acids
TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer
Chris D. Hermann, Benjamin Schoeps, Celina Eckfeld, Enkhtsetseg Munkhbaatar, Lukas Kniep, Olga Prokopchuk, Nils Wirges, Katja Steiger, Daniel Häußler, Percy Alexander Knolle et al. · 2021 · The Journal of Experimental Medicine
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, Maria, Zhang, Shuman, Pilarsky, Christian · 2021 · Frontiers in Cell and Developmental Biology
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Lena Wiedmann, Francesca Rigotti, Nuria Vaquero‐Siguero, Elisa Donato, Elisa Espinet, Iris Moll, Elisenda Alsina‐Sanchís, Hanibal Bohnenberger, Elena Fernández-Florido, Ronja Isabelle Mülfarth et al. · 2023 · Nature Communications
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
Ines de Santiago, Christopher Yau, Lara Rosaline Heij, Mark Ross Middleton, Florian M. Markowetz, Heike Irmgard Grabsch, Michael Loran Dustin, Shivan Sivakumar · 2019 · International Journal of Cancer
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
Qimin Zhou, Monika Posaric Bauden, Roland E. Andersson, Dingyuan Hu, György Marko‐Varga, Jianfeng Xu, Agata Sasor, Hua Dai, Krzysztof Pawłowski, Katarzyna Said Hilmersson et al. · 2020 · Journal of Translational Medicine
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability
Jason Robert Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Basil S. Bakir, Varun Sahu, Jinyang Li, Jun Zhao, Benoît Marchand, Maximilian D. Wengyn et al. · 2021 · Cancer Discovery
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer
Zhijun Zhou, Junxia Zhang, Chao Xu, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Xiuhui Shi, Xiaoping Li, Hanxiang Zhan, Wei Chen et al. · 2021 · EBioMedicine
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR
H Zhou, Aristeidis G. Telonis, Jing Yi, Nan L. Xia, Laura E. Biederman, Masaya Jimbo, Fernando F. Blanco, Eric R. Londin, Jonathan Robert Brody, Isidore Rigoutsos · 2016 · Cell Death and Disease
Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
Shivan Sivakumar, Ines de Santiago, Leon Chlon, Florian M. Markowetz · 2017 · PLoS Medicine
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype
Shruti Lal, Edwin C. Cheung, Mahsa Zarei, Ranjan Preet, Saswati N. Chand, Nicole Caroline Mambelli-Lisboa, Carmella Romeo, Matthew C. Stout, Eric R. Londin, Austin B. Goetz et al. · 2017 · Molecular Cancer Research
Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer
Veronique L. Veenstra, Andrea García-Garijo, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma · 2018 · Cancers
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy
Robert J. Torphy, Richard David Schulick, Yuwen Zhu · 2020 · Molecular Carcinogenesis
Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncology
Zahra Dantes, Hsi-Yu Yen, Nicole Pfarr, Christof Winter, Katja Steiger, Alexander Muckenhuber, Alexander Hennig, Sebastian Lange, Thomas Engleitner, Rupert Öllinger et al. · 2020 · JCI Insight
Epigenetic Alterations in Pancreatic Cancer Metastasis
Sarah S. Wang, Jihao Xu, Keely Y. Ji, Chang‐Il Hwang · 2021 · Biomolecules
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients
Shouhui Yang, Wei Tang, Azadeh Azizian, Jochen Gaedcke, Philipp Ströbel, Limin Wang, Helen Cawley, Yuuki Ohara, Paloma Valenzuela, Lin Zhang et al. · 2022 · Carcinogenesis
PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer
Gilles Rademaker, Grace A. Hernandez, Yurim Seo, Sumena Dahal, Lisa Miller‐Phillips, Alexander L. Li, Xianlu L. Peng, Changfei Luan, Longhui Qiu, Maude A. Liegeois et al. · 2025 · Nature
The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors
Louisa Bolm, S. Cigolla, Uwe A. Wittel, Ulrich Theodor Hopt, Tobias Keck, Dirk Rades, Peter Bronsert, Ulrich Friedrich Wellner · 2017 · Translational Oncology
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
Gebregiworgis, Teklab, Kano, Yoshihito, St-Germain, Jonathan, Radulovich, Nikolina, Udaskin, Molly L., Mentes, Ahmet, Huang, Richard, Poon, Betty P. K., He, Wenguang, Valencia-Sama, Ivette et al. · 2021 · Nature Communications
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
Fieke E. M. Froeling, Raffaella Casolino, Antonio Pea, Andrew Victor Biankin, David Kuang-Fu Chang, on behalf of Precision-Panc · 2021 · Journal of Clinical Medicine
Curing pancreatic cancer
Benno Traub, K.H. Link, Marko Kornmann · 2021 · Seminars in Cancer Biology
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA –Associated Pancreatic Cancer in the Clinical and Preclinical Setting
Chani Stossel, Maria Raitses‐Gurevich, Dikla Atias, Tamar Beller, Yulia Glick Gorman, Sharon Halperin, Eyal Peer, Robert Edward Denroche, Amy Xin Wei Zhang, Faiyaz Notta et al. · 2023 · Cancer Discovery
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing
Michelle M. Maurin, Mohammadreza Ranjouri, Cristina Megino‐Luque, Justin Y. Newberg, Dongliang Du, Katelyn Martin, Robert E Miner, Mollie S. Prater, Dave Keng Boon Wee, Barbara Ann Centeno et al. · 2023 · Nature Communications
Mcl‐1 targeting could be an intriguing perspective to cure cancer
Anna DE BLASIO, Renza Vento, Riccardo Di Fiore · 2018 · Journal of Cellular Physiology
Curcumin analogs: Their roles in pancreatic cancer growth and metastasis
Ganji Purnachandra Nagaraju, Leah Benton, Shipra Reddy Bethi, Mamoru Shoji, Bassel F. El‐Rayes · 2018 · International Journal of Cancer
Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells
Koen M.O. Galenkamp, Paulina Sosicka, Michael Jung, Maria Victoria Recouvreux, Yijuan Zhang, Matthew R. Moldenhauer, Giovanni Brandi, Hudson H. Freeze, Cosimo Commisso · 2020 · Cancer Discovery
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
Yuchen Zhang, Michael B. Ware, Mohammad Y. Zaidi, Amanda N. Ruggieri, Brian M. Olson, Hannah M. Komar, Matthew R. Farren, Ganji Purnachandra Nagaraju, Chao Zhang, Zhengjia Chen et al. · 2020 · Molecular Cancer Therapeutics
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Michael Eyres, Simone Lanfredini, Haonan Xu, Adam Burns, Andrew Blake, Frances W. Willenbrock, Robert David Goldin, Daniel Llwyd Hughes, Sophie L. Hughes, Asmita Thapa et al. · 2021 · Gastroenterology
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
Raefa Abou Khouzam, R. Shyama Prasad Rao, Goutham Hassan Venkatesh, Nagwa Ahmed Zeinelabdin, Stéphanie Buart, Maxime Meylan, Manjunath A. Nimmakayalu, Stéphane Terry, Salem Chouaı̈b · 2021 · Frontiers in Immunology
Gastrointestinal cancer organoids—applications in basic and translational cancer research
Therese Seidlitz, Daniel E. Stange · 2021 · Experimental & Molecular Medicine
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
Wenjing Zhang, Fuyan Shi, Yujia Kong, Yuting Li, Chao Sheng, Suzhen Wang, Qinghua Wang · 2021 · Cancer Medicine
PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione · 2023 · Cancers
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Selene E. Di Carlo, Jérôme Raffenne, Hugo Varet, A Ode, David Cabrerizo Granados, Merle Stein, Rachel Legendre, Jan Peter Tuckermann, Corinne Bousquet, Lucie Peduto · 2023 · Nature Immunology
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
Moamen Bydoun, Andra Mihaela Sterea, Henry Liptay, Andrea Uzans, Weei‐Yuarn Huang, Gloria J. Rodrigues, Ian C.G. Weaver, Hong Gu, David M. Waisman · 2018 · Molecular Oncology
Epithelial-Stromal Interactions in Pancreatic Cancer
Yaqing Zhang, Howard C. Crawford, Marina Pasca di Magliano · 2018 · Annual Review of Physiology
Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Mehran Taherian, Hua Wang, Huamin Wang · 2022 · Cells
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study
Philip A. Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi, Caio Max S. Rocha Lima, Angela Tatiana Alistar, Paul E. Oberstein, Talia Golan, Jean‐Philippe Metges et al. · 2024 · Journal of Clinical Oncology
Cilia in autophagy and cancer
Muqing Cao, Qing Zhong · 2015 · Cilia
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
Aesha I. Ali, Amanda J. Oliver, Tinaz Samiei, Jack D. Chan, Michael H. Kershaw, Clare Y. Slaney · 2019 · Frontiers in Oncology
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
Almeida, Palloma Porto, Cardoso, Cristina Padre, de Freitas, Leandro Martins · 2020 · BMC Cancer
The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer
Kai Duan, Gun-Ho Jang, Robert C. Grant, Julie M. Wilson, Faiyaz Notta, Grainne Mary O'Kane, Jennifer Jane Knox, Steve Gallinger, Sandra Elisabeth Fischer · 2021 · Scientific Reports
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
Neus Martínez‐Bosch, Helena Cristóbal, Mar Iglesias, Meritxell Gironella, Luís Barranco, Laura Visa, Domenico Calafato, Silvia Jiménez-Parrado, Julie Earl, Alfredo Carrato et al. · 2021 · EBioMedicine
Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
Hassan Sadozai, Animesh Acharjee, Serenella Eppenberger‐Castori, Beat Gloor, Thomas Gruber, Mirjam Schenk, Eva Karamitopoulou · 2021 · Frontiers in Immunology
The role of tumor heterogeneity in immune-tumor interactions
Shelby M. Knoche, Alaina C. Larson, Bailee H. Sliker, Brittany J. Poelaert, Joyce C. Solheim · 2021 · Cancer and Metastasis Reviews
Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines
Laia Gorchs, Helen Kaipe · 2021 · Cancers
Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures
Angela Oberhofer, Abel Jacobus Bronkhorst, Carsten Uhlig, Vida Ungerer, Stefan Holdenrieder · 2022 · Diagnostics
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
S. M. Zahid Hosen, Md. Nazim Uddin, Zhihong Xu, Benjamin J. Buckley, Chamini Jayamali Perera, Tony Pang, Alpha Raj Mekapogu, Mohammad Ali Moni, Faiyaz Notta, Steve Gallinger et al. · 2022 · Frontiers in Immunology
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
Samantha R. Guinn, Benedict Kinny‐Köster, Joseph A. Tandurella, Jacob T. Mitchell, Dimitrios N. Sidiropoulos, Melanie Loth, Melissa R. Lyman, Alexandra B. Pucsek, Daniel J. Zabransky, Jae Woo Lee et al. · 2024 · Cancer Research
Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
Liuliu Yang, Yuling Han, Tuo Zhang, Xue Dong, Jian Ge, Aadita Roy, Jiajun Zhu, Tiankun Lu, J. Jeya Vandana, Neranjan de Silva et al. · 2024 · Cell stem cell
Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness
Hiroyoshi Y. Tanaka, Kentaro Kitahara, Naoki Sasaki, Natsumi Nakao, Kae Sato, Hirokazu Narita, Hiroshi Shimoda, Michiya Matsusaki, Hiroshi Nishihara, Atsushi Masamune et al. · 2018 · Biomaterials
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4
Soledad A. Camolotto, Veronika K Belova, Luke A. Torre-Healy, Jeffery M. Vahrenkamp, Kristofer C. Berrett, Hannah Conway, Jill Shea, Chris Stubben, Richard A. Moffitt, Jason Gertz et al. · 2020 · Gut
Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine
Pierre‐Olivier Frappart, Thomas G. Hofmann · 2020 · Cancers
Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses
Shinkawa, Tomohiko, Ohuchida, Kenoki, Mochida, Yuki, Sakihama, Kukiko, Iwamoto, Chika, Abe, Toshiya, Ideno, Noboru, Mizuuchi, Yusuke, Shindo, Koji, Ikenaga, Naoki et al. · 2022 · Journal of Experimental & Clinical Cancer Research
Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis
Yunbo Qiao, Zejian Wang, Fangzhi Tan, Jun Chen, Jianxiang Lin, Jie Yang, Hui Li, Xiongjun Wang, Andrej Šali, Liye Zhang et al. · 2020 · Molecular Therapy
Next-generation therapies for pancreatic cancer
Conor W. Buckley, Eileen Mary O'Reilly · 2024 · Expert Review of Gastroenterology & Hepatology
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome
Thomas Kunzke, Benjamin Balluff, Annette Feuchtinger, Achim Buck, Rupert Langer, Birgit Luber, Florian Lordick, Horst F. Zitzelsberger, Michaela Aichler, Axel Karl Walch · 2017 · Oncotarget
Stromal heterogeneity in pancreatic cancer and chronic pancreatitis
Lena Häberle, Katja Steiger, Anna Melissa Schlitter, Sami Alexander Safi, Wolfram Trudo Knoefel, Mert Erkan, Iréne Esposito · 2018 · Pancreatology
Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC)
Jia Lin Er, Pei Ni Goh, Chen Yuan Lee, Ying Jie Tan, Ling‐Wei Hii, Chun‐Wai Mai, Felicia Fei‐Lei Chung, Chee‐Onn Leong · 2018 · APOPTOSIS
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets
Batoul Farran, Ganji Purnachandra Nagaraju · 2019 · Cytokine & Growth Factor Reviews
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
Group Young Researchers in Inflammatory Carcinogenesis, Anna Maxi Wandmacher, Anne‐Sophie Mehdorn, Susanne Sebens · 2021 · Cancers
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Heng‐Chung Kung, Jun Yu · 2023 · MedComm
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma
Aristeidis Papargyriou, Mulham Najajreh, David P. Cook, Carlo H. Maurer, Stefanie Bärthel, Hendrik A. Messal, Sakthi K. Ravichandran, Till Richter, Moritz A. Knolle, Thomas Metzler et al. · 2024 · Nature Biomedical Engineering
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer
Lukas Klein, Mengyu Tu, Niklas Krebs, Laura Urbach, Daniel T. Grimm, Muhammad Umair Latif, Frederike Penz, Anna Blandau, Xueyan Wu, Rebecca Diya Samuel et al. · 2025 · Nature Communications
Evolutionary fingerprints of epithelial-to-mesenchymal transition
Luigi Perelli, Li Zhang, Sarah M. Mangiameli, Francesca Giannese, Krishnan K. Mahadevan, Fuduan Peng, Francesca Citron, Hania Khan, Courtney N. Le, Enrico Gurreri et al. · 2025 · Nature
High-throughput genomic profiling of tumor-infiltrating leukocytes
Aaron M. Newman, Ash A. Alizadeh · 2016 · Current Opinion in Immunology
MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature
Deena M.A. Gendoo, Michael Zon, Vandana Sandhu, Venkata SK. Manem, Natchar Ratanasirigulchai, Gregory M. Chen, Levi Waldron, Benjamin Haibe‐Kains · 2019 · Scientific Reports
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
Abdessamad El Kaoutari, Nicolas Alejandro Fraunhoffer, Owen Hoare, Carlos Teyssedou, Philippe Soubeyran, Odile Gayet, Julie Roques, Gwen Alyce Lomberk, Raul A. Urrutia, Nelson Dusetti et al. · 2021 · EBioMedicine
Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells
Susmita Barman, Iram Fatima, Amar B. Singh, Punita Dhawan · 2021 · International Journal of Molecular Sciences
S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
Yuan Chen, Chengcheng Wang, Jianlu Song, Ruiyuan Xu, Rexiati Ruze, Yupei Zhao · 2021 · Frontiers in Immunology
Subtyping Pancreatic Cancer
Andrew Victor Biankin, Anirban Maitra · 2015 · Cancer Cell
The Role of the Microbiome in Pancreatic Cancer
Koji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro · 2022 · Cancers
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer
Francesco De Sanctis, Silvia Dusi, Simone Caligola, Cristina Anselmi, Varvara Petrova, Barbara Rossi, Gabriele Angelini, Michael Erdeljan, Stefan Wöll, Anna Melissa Schlitter et al. · 2024 · Immunity
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Enrique Rozengurt, Guido Eibl · 2026 · Signal Transduction and Targeted Therapy
Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling
Samuel Gonçalves-Ribeiro, Rebeca Sanz Pamplona, Alvaro Daniel Vidal, Xavier Sanjuán, Natalia Guillén Díaz-Maroto, A. Soriano, Jordi Guardiola, Nerea Albert, Maria Mercedes Martinez-Villacampa, Iris Terán López et al. · 2017 · Annals of Oncology
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers
Laura Follia, Giulio Ferrero, Giorgia Mandili, Marco Beccuti, Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli, Andrea Evangelista, Hiroyuki Katayama, Wang Hong et al. · 2019 · Frontiers in Oncology
The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Nesrin M. Hasan, Nita Ahuja · 2019 · Cancers
Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
Kanchan Singh, Melissa A. Pruski, Rachael Bland, Mamoun Younes, Sushovan Guha, Nirav C Thosani, Anirban Maitra, Brooks D. Cash, Florencia M. McAllister, Craig D. Logsdon et al. · 2020 · Laboratory Investigation